A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2053
Clinical trial NCT06229548 · COMPLETED
Trial details
- NCT number
- NCT06229548
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-08
- Primary completion
- 2024-12-23
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.